JP2022526720A5 - - Google Patents
Info
- Publication number
- JP2022526720A5 JP2022526720A5 JP2021555415A JP2021555415A JP2022526720A5 JP 2022526720 A5 JP2022526720 A5 JP 2022526720A5 JP 2021555415 A JP2021555415 A JP 2021555415A JP 2021555415 A JP2021555415 A JP 2021555415A JP 2022526720 A5 JP2022526720 A5 JP 2022526720A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- seq
- car
- chimeric antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2019107136 | 2019-03-13 | ||
| RU2019107136A RU2742000C2 (ru) | 2019-03-13 | 2019-03-13 | Выделенный альтернативный внутриклеточный сигнальный домен химерного антигенного рецептора и включающий его химерный антигенный рецептор |
| PCT/RU2020/000136 WO2020185121A2 (ru) | 2019-03-13 | 2020-03-13 | Выделенный альтернативный внутриклеточный сигнальный домен химерного антигенного рецептора и включающий его химерный антигенный рецептор |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022526720A JP2022526720A (ja) | 2022-05-26 |
| JP2022526720A5 true JP2022526720A5 (enExample) | 2023-03-17 |
| JP7735186B2 JP7735186B2 (ja) | 2025-09-08 |
Family
ID=72425914
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021555415A Active JP7735186B2 (ja) | 2019-03-13 | 2020-03-13 | キメラ抗原受容体の代替の細胞内シグナル伝達ドメイン |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US12540169B2 (enExample) |
| EP (1) | EP3974444A4 (enExample) |
| JP (1) | JP7735186B2 (enExample) |
| KR (1) | KR20220157861A (enExample) |
| CN (1) | CN114206918A (enExample) |
| RU (1) | RU2742000C2 (enExample) |
| WO (1) | WO2020185121A2 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201713078D0 (en) * | 2017-08-15 | 2017-09-27 | Adaptimmune Ltd | T Cell Modification |
| EP3773918A4 (en) | 2019-03-05 | 2022-01-05 | Nkarta, Inc. | CD19 DIRECTED CHIMERIC ANTIGEN RECEPTORS AND THEIR USES IN IMMUNOTHERAPY |
| CN116601174A (zh) * | 2020-10-12 | 2023-08-15 | 索伦托药业有限公司 | Cd19定向的嵌合抗原受体构建体 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| US5399346A (en) | 1989-06-14 | 1995-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Gene therapy |
| US5585362A (en) | 1989-08-22 | 1996-12-17 | The Regents Of The University Of Michigan | Adenovirus vectors for gene therapy |
| US5350674A (en) | 1992-09-04 | 1994-09-27 | Becton, Dickinson And Company | Intrinsic factor - horse peroxidase conjugates and a method for increasing the stability thereof |
| HK1047109A1 (zh) | 1999-10-15 | 2003-02-07 | University Of Massachusetts | 作为指定基因干预工具的rna干预轨迹基因 |
| US6326193B1 (en) | 1999-11-05 | 2001-12-04 | Cambria Biosciences, Llc | Insect control agent |
| AU2001275474A1 (en) | 2000-06-12 | 2001-12-24 | Akkadix Corporation | Materials and methods for the control of nematodes |
| US20130266551A1 (en) * | 2003-11-05 | 2013-10-10 | St. Jude Children's Research Hospital, Inc. | Chimeric receptors with 4-1bb stimulatory signaling domain |
| EP2970985A1 (en) * | 2013-03-14 | 2016-01-20 | Fred Hutchinson Cancer Research Center | Compositions and methods to modify cells for therapeutic objectives |
| FI2997141T3 (fi) * | 2013-05-13 | 2022-12-15 | CD19-spesifinen kimeerinen antigeenireseptori ja sen käyttöjä | |
| WO2015069922A2 (en) * | 2013-11-06 | 2015-05-14 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Alk antibodies, conjugates, and chimeric antigen receptors, and their use |
| ES2836743T3 (es) * | 2014-06-02 | 2021-06-28 | Us Health | Receptores de antígeno quiméricos que seleccionan como diana CD-19 |
| EP4643874A3 (en) | 2015-12-22 | 2026-02-11 | Novartis AG | Mesothelin chimeric antigen receptor (car) and antibody against pd-l1 inhibitor for combined use in anticancer therapy |
| US11578115B2 (en) * | 2017-01-10 | 2023-02-14 | The General Hospital Corporation | Chimeric antigen receptors based on alternative signal 1 domains |
-
2019
- 2019-03-13 RU RU2019107136A patent/RU2742000C2/ru active
-
2020
- 2020-03-13 JP JP2021555415A patent/JP7735186B2/ja active Active
- 2020-03-13 US US17/438,398 patent/US12540169B2/en active Active
- 2020-03-13 EP EP20770459.4A patent/EP3974444A4/en active Pending
- 2020-03-13 KR KR1020217032967A patent/KR20220157861A/ko not_active Ceased
- 2020-03-13 WO PCT/RU2020/000136 patent/WO2020185121A2/ru not_active Ceased
- 2020-03-13 CN CN202080035754.4A patent/CN114206918A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230034117A1 (en) | Compositions and methods for regulating car t cells | |
| JP2022113880A5 (enExample) | ||
| JP2020513829A5 (enExample) | ||
| CN111235113A (zh) | 包含嵌合抗原受体的免疫细胞及其用途 | |
| JP2020533958A5 (enExample) | ||
| JP2020525536A5 (enExample) | ||
| JP2019536452A5 (enExample) | ||
| JP2017512054A (ja) | 三官能性ｔ細胞−抗原カプラ及び方法並びにこれらの使用 | |
| JP2018515123A5 (enExample) | ||
| JP2021515598A5 (enExample) | ||
| JP2022534680A5 (enExample) | ||
| JP2017524367A5 (enExample) | ||
| JP2017500869A5 (enExample) | ||
| JP2018535701A5 (enExample) | ||
| JP7227630B2 (ja) | Ｙ１８２ｔ突然変異を有するｔ細胞－抗原カプラおよびその方法ならびに使用 | |
| JP7252651B2 (ja) | Ｃｄ３３発現がんを標的とするための組成物および方法 | |
| JP2020513754A5 (enExample) | ||
| US20230277670A1 (en) | Chimeric molecules providing targeted costimulation for adoptive cell therapy | |
| JP2022526720A5 (enExample) | ||
| JP2023514232A5 (enExample) | ||
| JP2022545815A5 (enExample) | ||
| JP2021520780A (ja) | Ｎｋｇ２ｄキメラ抗原受容体 | |
| JP2022513372A5 (enExample) | ||
| JP2023553159A5 (enExample) | ||
| JP2023524132A5 (enExample) |